European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.35% to 1,962.14 on the S&P Europe Select ADR Index, which is up 0.17% for the week so far.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and petroleum refiner Equinor (EQNR), which rose 3.2% and 2.3%, respectively. They were followed by oil and gas company Eni (E) and telecommunications firm Nokia (NOK), which were up 0.8% and 0.7%, respectively.

The decliners from continental Europe were led by biopharmaceutical companies Cellectis (CLLS) and argenx (ARGX), which dropped 2.5% and 2.1%, respectively. They were followed by biopharmaceutical firm DBV Technologies (DBVT) and biotech company Evaxion (EVAX), which lost 1.8% and 1.6%, respectively.

The gainers from the UK were led by biopharmaceutical company NuCana (NCNA) and biotech firm Trinity Biotech (TRIB), which advanced 4.1% and 3.1% respectively. They were followed by oil and gas companies Shell (SHEL) and BP (BP), which increased 1.7% and 0.9% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which fell 7.4% and 3.9% respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Akari Therapeutics (AKTX), which were down 2.3% and 1.3% respectively.